Serum IGF-1 in the diagnosis of acromegaly and the profile of patients with elevated igf-1 but normal glucose-suppressed growth hormone

Endocrine Practice

Volumn 18, Issue 6, 2012, Pages 817-825

  Subbarayan, Sreevidya K ^a   Fleseriu, Maria ^b   Gordon, Murray B ^c   Brzana, Jessica A ^b   Kennedy, Laurence ^a   Faiman, Charles ^a   Hatipoglu, Betul A ^a   Prayson, Richard A ^a   Delashaw, Johnny B ^b   Weil, Robert J ^a   Hamrahian, Amir H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ACROMEGALY; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; RETROSPECTIVE STUDY;

ACROMEGALY; ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84871366665     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11324.OR     Document Type: Article

References (28)

1. Cordero RA, Barkan AL. Current diagnosis of acromegaly. Rev Endocr Metab Disord. 2008; 9: 13-19.
2. Barkan AL, Beitins IZ, Kelch RP. Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion. J Clin Endocrinol Metab. 1988; 67: 69-73.
3. Lunt H, Tucker AJ, Bullen H, Gibbs C, Wilkin TJ. Overnight urinary growth hormone measurement in the diagnosis of acromegaly. Clin Endocrinol (Oxf). 1990; 33: 205-212.
4. Giustina A, Barkan A, Casanueva FF, et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab. 2000; 85: 526-529.
5. Clemmons DR, Van Wyk JJ. Factors controlling blood concentration of somatomedin C. Clin Endocrinol Metab. 1984; 13: 113-143.
6. Carmichael JD, Bonert VS, Mirocha JM, Melmed S. The utility of oral glucose tolerance testing for diagnosis and assessment of treatment outcomes in 166 patients with acromegaly. J Clin Endocrinol Metab. 2009; 94: 523-527.
7. Bidlingmaier M, Strasburger CJ. Growth hormone assays: current methodologies and their limitations. Pituitary. 2007; 10: 115-119.
8. Barkan A, Bronstein MD, Bruno OD, et al. Management of acromegaly in Latin America: expert panel recommendations. Pituitary. 2010; 13: 168-175.
9. Cook DM, Ezzat S, Katznelson L, et al. AACE medical guidelines for clinical practice for the diagnosis and treatment of acromegaly [published corrections appear in Endocr Pract. 2005; 11: 144 and Endocr Pract. 2008; 14: 802-803]. Endocr Pract. 2004; 10: 213-225.
10. Giustina A, Chanson P, Bronstein MD, et al. A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab. 2010; 95: 3141-3148.
11. Growth Hormone Research Society; Pituitary Society. Biochemical assessment and long-term monitoring in patients with acromegaly: statement from a joint consensus conference of the Growth Hormone Research Society and the Pituitary Society. J Clin Endocrinol Metab. 2004; 89: 3099-3102.
12. Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly-2011 update: executive summary. Endocr Pract. 2011; 17: 636-646.
13. Freda PU, Beckers AM, Katznelson L, et al. Pituitary incidentaloma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96: 894-904.
14. Rosario PW. Normal values of serum IGF-1 in adults: results from a Brazilian population. Arq Bras Endocrinol Metabol. 2010; 54: 477-481.
15. Freda PU, Post KD, Powell JS, Wardlaw SL. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. J Clin Endocrinol Metab. 1998; 83: 3808-3816.
16. Ribeiro-Oliveira A Jr, Faje AT, Barkan AL. Limited utility of oral glucose tolerance test in biochemically active acromegaly. Eur J Endocrinol. 2011; 164: 17-22.
17. Dimaraki EV, Jaffe CA, DeMott-Friberg R, Chandler WF, Barkan AL. Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. J Clin Endocrinol Metab. 2002; 87: 3537-3542.
18. Dobrashian RD, O'Halloran DJ, Hunt A, Beardwell CG, Shalet SM. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly. Clin Endocrinol (Oxf). 1993; 38: 589-593.
19. Clemmons DR, Van Wyk JJ, Ridgway EC, Kliman B, Kjellberg RN, Underwood LE. Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med. 1979; 301: 1138-1142.
20. Frystyk J, Freda P, Clemmons DR. The current status of IGF-I assays-a 2009 update. Growth Horm IGF Res. 2010; 20: 8-18.
21. Parkinson C, Renehan AG, Ryder WD, O'Dwyer ST, Shalet SM, Trainer PJ. Gender and age influence the relationship between serum GH and IGF-I in patients with acromegaly. Clin Endocrinol (Oxf). 2002; 57: 59-64.
22. Parkinson C, Ryder WD, Trainer PJ. The relationship between serum GH and serum IGF-I in acromegaly is gender-specific. J Clin Endocrinol Metab. 2001; 86: 5240-5244.
23. Marzullo P, Di Somma C, Pratt KL, et al. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults. J Clin Endocrinol Metab. 2001; 86: 3001-3008.
24. Röjdmark S, Brismar K. Decreased IGF-I bioavailability after ethanol abuse in alcoholics: partial restitution after short-term abstinence. J Endocrinol Invest. 2001; 24: 476-482.
25. Muller AF, Janssen JA, Lamberts SW, et al. Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion. Clin Endocrinol (Oxf). 2001; 55: 461-467.
26. Frystyk J. Utility of free IGF-I measurements. Pituitary. 2007; 10: 181-187.
27. Stoffel-Wagner B, Springer W, Bidlingmaier F, Klingmüller D. A comparison of different methods for diagnosing acromegaly. Clin Endocrinol (Oxf). 1997; 46: 531-537.
28. Granada ML, Ulied A, Casanueva FF, et al. Serum IGF-I measured by four different immunoassays in patients with adult GH deficiency or acromegaly and in a control population. Clin Endocrinol (Oxf). 2008; 68: 942-950.